-
公开(公告)号:US20100173985A1
公开(公告)日:2010-07-08
申请号:US12660351
申请日:2010-02-25
申请人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
发明人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
IPC分类号: A61K31/352 , C07D311/04 , C07C69/76 , C07C233/64 , C12N5/00 , A61K31/235 , A61K31/165 , A61P35/00
CPC分类号: C07D311/60 , C07C69/88 , C07C235/54 , C07C2601/14 , C07C2602/10
摘要: The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers.
摘要翻译: 本发明涉及合成绿茶衍生的多酚类化合物,其合成方式及其在抑制蛋白酶体活性和治疗癌症中的用途。 本发明还涉及可用于抑制蛋白酶体和治疗癌症的方法中的药物组合物。
-
公开(公告)号:US09920084B2
公开(公告)日:2018-03-20
申请号:US14240067
申请日:2012-08-23
申请人: Masad J. Damha , Matthew Hassler , Tak-Hang Chan , Mallikarjuna Reddy Nandyala , Robert Alexander Donga
发明人: Masad J. Damha , Matthew Hassler , Tak-Hang Chan , Mallikarjuna Reddy Nandyala , Robert Alexander Donga
IPC分类号: C07D233/60 , C07D333/00 , C40B80/00 , C07F9/54 , C07H19/02 , C07H21/00 , C07F9/655 , C07F9/6558 , C07H21/02 , C40B50/16
CPC分类号: C07F9/54 , C07D233/60 , C07F9/5407 , C07F9/5442 , C07F9/5456 , C07F9/65515 , C07F9/65586 , C07H19/02 , C07H21/00 , C07H21/02 , C40B50/16 , C40B80/00
摘要: The invention relates to the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. In another aspect, the invention relates to compounds of formula (II) processes for making these compounds, and the use thereof in the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. The invention also relates to methods of synthesis of oligomers, including but not limited to oligopeptides, oligosaccharides and oligonucleotides, particularly oligoribonucleotides and also oligodeoxyribonucleotides, in solution systems, and ionic tag linkers for use in methods provided herein.
-
公开(公告)号:US08058310B2
公开(公告)日:2011-11-15
申请号:US12660351
申请日:2010-02-25
申请人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
发明人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
IPC分类号: A61K31/235 , A61K31/16
CPC分类号: C07D311/60 , C07C69/88 , C07C235/54 , C07C2601/14 , C07C2602/10
摘要: The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers.
摘要翻译: 本发明涉及合成绿茶衍生的多酚类化合物,其合成方式及其在抑制蛋白酶体活性和治疗癌症中的用途。 本发明还涉及可用于抑制蛋白酶体和治疗癌症的方法中的药物组合物。
-
公开(公告)号:US20100093975A1
公开(公告)日:2010-04-15
申请号:US12530890
申请日:2008-03-12
申请人: Tak-Hang Chan , Xun He
发明人: Tak-Hang Chan , Xun He
IPC分类号: C07K7/06 , C07D403/14
CPC分类号: C07D233/61 , C07K1/042 , C08G73/0616
摘要: The present disclosure relates to structurally defined imidazolium-type ionic oligomers of the formula: wherein n is an integer ranging from 1 to 20; A is N or m is an integer ranging from 1 to 5; X is selected from the group consisting of Br, OTf, CF3CO2, CH3CO2, BF4, PF6, NTf2, F, Cl and I; and R is selected from the group consisting of hydrogen and C1-10 alkyl. The imidazolium-type ionic oligomers lend themselves as soluble/solid supports for biopolymer synthesis.
摘要翻译: 本公开涉及结构上定义的下式的咪唑鎓型离子低聚物:其中n是1至20的整数; A为N或m为1至5的整数; X选自Br,OTf,CF 3 CO 2,CH 3 CO 2,BF 4,PF 6,NTf 2,F,Cl和I; 并且R选自氢和C 1-10烷基。 咪唑型离子低聚物本身可用作生物聚合物合成的可溶/固体支持体。
-
公开(公告)号:US07358383B2
公开(公告)日:2008-04-15
申请号:US10764728
申请日:2004-01-26
申请人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
发明人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
IPC分类号: C07C69/76
CPC分类号: C07D311/60 , C07C69/88 , C07C235/54 , C07C2601/14 , C07C2602/10
摘要: The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers.
-
公开(公告)号:US10059736B2
公开(公告)日:2018-08-28
申请号:US11908487
申请日:2006-03-15
申请人: Tak-Hang Chan , Masad J. Damha , Weishi Miao , Robert Alexander Donga , Xun He
发明人: Tak-Hang Chan , Masad J. Damha , Weishi Miao , Robert Alexander Donga , Xun He
CPC分类号: C07H21/00 , C07H3/06 , C07K1/023 , C07K1/04 , Y02P20/542
摘要: The present invention relates to ionic liquids for use in chemical applications and capable of serving the dual function of solvent and liquid support. The ionic liquid lends itself to a method of synthesizing oligomers selected from the group consisting of oligopeptides, oligosaccharides and oligonucleotides, comprising contacting a first monomer unit with an ionic liquid at reaction conditions to provide an ionic liquid bound monomer unit; and contacting the ionic liquid bound monomer unit with at least one further monomer unit at reaction conditions to provide an ionic liquid bound oligomer comprising from 2 to 30 monomer units. The method lends itself to large scale manufacture of oligopeptides, oligosaccharides and oligonucleotides.
-
公开(公告)号:US20100041869A1
公开(公告)日:2010-02-18
申请号:US11908487
申请日:2006-03-15
申请人: Tak-Hang Chan , Masad J. Damha , Weishi Miao , Robert Alexander Donga , Xun He
发明人: Tak-Hang Chan , Masad J. Damha , Weishi Miao , Robert Alexander Donga , Xun He
CPC分类号: C07H21/00 , C07H3/06 , C07K1/023 , C07K1/04 , Y02P20/542
摘要: The present invention relates to ionic liquids for use in chemical applications and capable of serving the dual function of solvent and liquid support. The ionic liquid lends itself to a method of synthesizing oligomers selected from the group consisting of oligopeptides, oligosaccharides and oligonucleotides, comprising contacting a first monomer unit with an ionic liquid at reaction conditions to provide an ionic liquid bound monomer unit; and contacting the ionic liquid bound monomer unit with at least one further monomer unit at reaction conditions to provide an ionic liquid bound oligomer comprising from 2 to 30 monomer units. The method lends itself to large scale manufacture of oligopeptides, oligosaccharides and oligonucleotides.
摘要翻译: 本发明涉及用于化学应用并能够起到溶剂和液体载体的双重作用的离子液体。 离子液体本身适用于合成选自寡肽,寡糖和寡核苷酸的低聚物的方法,包括在反应条件下使第一单体单元与离子液体接触以提供离子液体结合的单体单元; 以及在反应条件下使离子液体结合的单体单元与至少一个其它单体单元接触,以提供包含2至30个单体单元的离子液体结合的低聚物。 该方法适合大规模生产寡肽,寡糖和寡核苷酸。
-
公开(公告)号:US08563607B2
公开(公告)日:2013-10-22
申请号:US13271058
申请日:2011-10-11
申请人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
发明人: Q. Ping Dou , Tak-Hang Chan , David M. Smith
IPC分类号: A61K31/235
CPC分类号: C07D311/60 , C07C69/88 , C07C235/54 , C07C2601/14 , C07C2602/10
摘要: The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers.
摘要翻译: 本发明涉及合成绿茶衍生的多酚类化合物,其合成方式及其在抑制蛋白酶体活性和治疗癌症中的用途。 本发明还涉及可用于抑制蛋白酶体和治疗癌症的方法中的药物组合物。
-
公开(公告)号:US08168801B2
公开(公告)日:2012-05-01
申请号:US12530890
申请日:2008-03-12
申请人: Tak-Hang Chan , Xun He
发明人: Tak-Hang Chan , Xun He
IPC分类号: C07D403/06 , C07D403/14
CPC分类号: C07D233/61 , C07K1/042 , C08G73/0616
摘要: The present disclosure relates to structurally defined imidazolium-type ionic oligomers of the formula: wherein n is an integer ranging from 1 to 20; A is N or m is an integer ranging from 1 to 5; X is selected from the group consisting of Br, OTf, CF3CO2, CH3CO2, BF4, PF6, NTf2, F, Cl and I; and R is selected from the group consisting of hydrogen and C1-10 alkyl. The imidazolium-type ionic oligomers lend themselves as soluble/solid supports for biopolymer synthesis.
摘要翻译: 本公开涉及结构上定义的下式的咪唑鎓型离子低聚物:其中n是1至20的整数; A为N或m为1至5的整数; X选自Br,OTf,CF 3 CO 2,CH 3 CO 2,BF 4,PF 6,NTf 2,F,Cl和I; 并且R选自氢和C 1-10烷基。 咪唑型离子低聚物本身可用作生物聚合物合成的可溶/固体支持体。
-
20.
公开(公告)号:US20080311183A1
公开(公告)日:2008-12-18
申请号:US11915664
申请日:2006-05-29
IPC分类号: A61K9/127 , A61K31/683 , A61K31/695 , A61P35/04 , A61K31/215 , A61K31/10
CPC分类号: C07C305/14 , A61K31/282 , A61K31/661 , A61K31/6615 , A61K31/662 , A61K31/695 , A61K45/06 , C07F9/113 , C07F9/3891 , C07F9/4065
摘要: The present invention relates to compounds for the inhibition of pyruvate kinase and ATP production which are capable of inhibiting cancer cells proliferation.
摘要翻译: 本发明涉及能够抑制癌细胞增殖的抑制丙酮酸激酶和ATP产生的化合物。
-
-
-
-
-
-
-
-
-